Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Cipla
Queensland Health
Harvard Business School
McKesson
Merck
Federal Trade Commission
Covington
US Army

Generated: October 22, 2017

DrugPatentWatch Database Preview

Insulin zinc susp recombinant human - Generic Drug Details

« Back to Dashboard

What are the generic sources for insulin zinc susp recombinant human and what is the scope of insulin zinc susp recombinant human freedom to operate?

Insulin zinc susp recombinant human
is the generic ingredient in two branded drugs marketed by Novo Nordisk Inc and Lilly, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-eight drug master file entries for insulin zinc susp recombinant human.

Summary for Generic Name: insulin zinc susp recombinant human

US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: see list38
Clinical Trials: see list11,911
Drug Prices:see low prices
DailyMed Link:insulin zinc susp recombinant human at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
HUMULIN L
insulin zinc susp recombinant human
INJECTABLE;INJECTION019377-002Sep 30, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Novo Nordisk Inc
NOVOLIN L
insulin zinc susp recombinant human
INJECTABLE;INJECTION019965-001Jun 25, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
AstraZeneca
Boehringer Ingelheim
Baxter
Mallinckrodt
UBS
Julphar
US Department of Justice
Chinese Patent Office
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot